Skip to main content

Table 2 The correlation analysis of CHA2DS2-VASc and clinical data in STEMI patients

From: Predictive value of CHADS2 and CHA2DS2-VASc scores for coronary artery lesions and in-hospital prognosis of patients with acute ST-segment elevation myocardial infarction

Index

Low group (n = 184)

Middle group (n = 193)

High group (n = 147)

F/χ2

P

Age

52.62 ± 8.7

60.26 ± 10.60

72.90 ± 9.98

178.591

 < 0.001

Gender

   

180.232

 < 0.001

Female

1 (1.2%)

19 (3.6%)

83 (15.8%)

  

Male

183 (34.9%)

174 (33.2%)

64 (12.2%)

  

LVEF

59.58 ± 10.0

57.26 ± 10.42

56.14 ± 10.0

2.892

0.056

LDL-C

3.10 ± 0.86

2.93 ± 0.92

2.83 ± 1.00

3.038

0.048

BNP

605.6 (219.3–1214.3)

944.8 (381.2–1905)

2302.7 (1019.5–4585.5)

86.382

 < 0.001

LP(a)

14.6(9.1–30)

13.8(8–27.2)

16.9(10.5–31.9)

3.621

0.167

Hypertension

55 (10.5%)

128 (24.4%)

109 (20.8%)

80.289

 < 0.001

Hyperlipidemia

153 (29.2%)

163 (31.1%)

119 (22.7%)

0.978

0.645

Diabetes

21 (4.0%)

85 (16.2%)

73 (13.9%)

68.894

 < 0.001

TIA

0 (0%)

9 (1.7%)

48 (9.2%)

109.581

 < 0.001

Atrial fibrillation

2 (0.4%)

9 (1.7%)

15 (2.86%)

15.253

 < 0.001

Killip

1

151 (28.8%)

91 (17.4%)

40 (7.6%)

138.958

 < 0.001

2

30 (5.7%)

89 (17.0%)

73 (14.0%)

  

 ≥ 3

3 (0.6%)

13 (2.5%)

34 (6.5%)

  

History of PCI

9 (1.7%)

7 (1.3%)

5 (1.0%)

0.582

0.762